Correlation Between Maxigen Biotech and Tsh Biopharmoration

Can any of the company-specific risk be diversified away by investing in both Maxigen Biotech and Tsh Biopharmoration at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maxigen Biotech and Tsh Biopharmoration into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Maxigen Biotech and tsh biopharmoration, you can compare the effects of market volatilities on Maxigen Biotech and Tsh Biopharmoration and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maxigen Biotech with a short position of Tsh Biopharmoration. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maxigen Biotech and Tsh Biopharmoration.

Diversification Opportunities for Maxigen Biotech and Tsh Biopharmoration

0.02

Correlation Coefficient

Maxigen Biotech  Tsh Biopharmoration

Significant diversification

The 3 months correlation between Maxigen and Tsh is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Maxigen Biotech and tsh biopharmoration in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on tsh biopharmoration and Maxigen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maxigen Biotech are associated (or correlated) with Tsh Biopharmoration. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of tsh biopharmoration has no effect on the direction of Maxigen Biotech i.e., Maxigen Biotech and Tsh Biopharmoration go up and down completely randomly.

Pair Corralation between Maxigen Biotech and Tsh Biopharmoration

Assuming the 90 days trading horizon Maxigen Biotech is expected to generate 1.1 times more return on investment than Tsh Biopharmoration. However, Maxigen Biotech is 1.1 times more volatile than tsh biopharmoration. It trades about 0.18 of its potential returns per unit of risk. tsh biopharmoration is currently generating about -0.19 per unit of risk. If you would invest  4,455  in Maxigen Biotech on September 24, 2024 and sell it today you would earn a total of  235.00  from holding Maxigen Biotech or generate 5.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Maxigen Biotech  vs.  tsh biopharmoration

Maxigen Biotech

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Maxigen Biotech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Maxigen Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

tsh biopharmoration

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in tsh biopharmoration are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Tsh Biopharmoration is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Maxigen Biotech and Tsh Biopharmoration

The main advantage of trading using opposite Maxigen Biotech and Tsh Biopharmoration positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maxigen Biotech position performs unexpectedly, Tsh Biopharmoration can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tsh Biopharmoration will offset losses from the drop in Tsh Biopharmoration's long position.

The idea behind Maxigen Biotech and tsh biopharmoration pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.